Introduction not yet known there have been several previous reports that in vitro CYP 2B1 can metabolize N-nitrosomethylalkylamines Oesophageal cancer is the seventh most common cancer in with the necessary selectivity for the α-carbon of the larger the world. The majority of these tumours are squamous cell alkyl group (8,14-19), which raises the possibility that this carcinomas, although there is a significant and rising incidence new P450 may be the nitrosamine-metabolizing enzyme of rat of adenocarcinoma (1) . Identification of the cause of this cancer oesophagus. is very important because oesophageal cancer is incurable. In the UK 77% of victims are dead within a year of diagnosis and the 5 year survival is only 7% (2) . There is more than a Materials and methods 100-fold difference in the incidence of oesophageal cancer in Reverse transcription (RT) and PCR amplification of cytochrome P450 mRNAs different parts of the world and there have been rapid changes RT-PCR was performed using degenerate primers targeted at conserved in incidence with time. For example, the incidence among regions of P450s of the 2A, 2B and 2E sub-families. Rat oesophageal mucosa was obtained by stripping the surrounding muscle layer from rat oesophagus males in Singapore fell by 3.6% per annum between 1970 and as previously described (7). The mucosa were immediately placed into liquid 1980 (3) . These geographical and temporal variations suggest nitrogen and powdered with a pestle and mortar and total RNA prepared as that oesophageal cancer is caused by exposure to carcinogens. any other except lung cancer (4,5). Because of these observa- (Promega) . PCR was performed using 1 µl of the reverse transcription mixture, tions there is considerable interest in carcinogen activation in 0.5 µmol each primer, 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , the oesophagus. 0.2 mM dNTPs and 1-2 U Taq polymerase (AmpliTaq; Perkin Elmer) in a 50 µl reaction. Primers were expected to amplify~350 bp of cDNA. The primers were (Y ϭ C or T; R ϭ A or G; V ϭ A, G or C; W ϭ A or T; Abbreviations: RACE, rapid amplification of cDNA ends; R; reverse transcription; UTR, untranslated region.
H ϭ A, C or T): for CYP2A, forward, 5Ј-GGCTTYYTGYTRCTCATGAA, Fig. 1 . The cDNA sequence of the cytochrome P450 identified in the oesophagus. The start codon is at position 18, the stop codon at 1500 and the polyadenylation signal at 1852. This sequence was determined from three independent cDNA library clones. The sequence between 964 and 1310 was confirmed by sequencing a fragment amplified by RT-PCR, the sequence between 759 and 1122 by nested 5Ј-RACE and the sequence between 1140 and 1894 by nested 3Ј-RACE. The forward primer used for 3Ј-RACE shown in Figure 3A began at 960 and the reverse, 5Ј-RACE primer began at 1251.
and reverse, 5Ј-CCVAARCAGWTYCGCTTTCC; for CYP2B, forward, Rapid amplification of cDNA ends (RACE) and nested RACE 5Ј-GGHTTCCTGCTCATGCTCAA, and reverse, 5Ј-CCAAGACAAATVCGOesophageal poly(A) RNA was obtained from oesophageal total RNA CTTYCC; for CYP2E, forward, 5Ј-GGGCTCCTGATYCTCATGAA, and using oligo(dT)-Dynabeads (Dynal, UK) according to the manufacturer's reverse, 5Ј-CCARCACACACDCGYTTTCC. Cycling conditions were 1 cycle instructions. This RNA was reverse transcribed with Superscript II reverse of 94°C for 1 min, followed by 30 cycles of 94°C for 30 s, 60°C for 1.5 min transcriptase (Life Technologies) from an oligo(dT) primer according to the and 72°C for 2 min, and a final extension at 72°C for 5 min. PCR products manufacturer's instructions. Double-stranded DNA was made using a Marathon were ligated into pPCR-Script (Stratagene), cloned and analysed by DNA cDNA synthesis kit (Clontech) according to the manufacturer's instructions. sequencing. The procedures described above were also carried out with total 5Ј-and 3Ј-RACE PCR amplifications were performed with the long distance RNA prepared from rat liver. Primers used by Shen et al. (21) to amplify a proof-reading DNA polymerase rTth (Perkin Elmer) using the gene-specific fragment of a novel P450 cDNA from mouse embryo fibroblast cells were primers 5Ј-TCATTCTTCTTCAGTGCCCCATTGGC-3Ј and 5Ј-CTCAAGalso used. The downstream primer was designed to anneal to the sequence TACCCCCATGTTGCAGAG-3Ј, respectively, and the adapter primer AP1 of the cDNA at the position of the conserved cysteine at about position 435 (5Ј-CCATCCTAATACGACTCACTATAGGGC; Clontech). Nested RACEof the amino acid sequences of all P450s; the highly degenerate inosine-PCR was performed using the nested gene-specific primers 5Ј-GTGTGGCcontaining upstream primer was designed to anneal to cDNA of any P450 of AGACCAATCGGGACAAG-3Ј and 5Ј-CATTGTTCCGAGGGTACCTGCTfamilies 1, 2 and 3. The primers used were: forward, 5Ј-ARRITSCAIVAR-CCC-3Ј together with the nested adapter primer AP2 (5Ј-ACTCACTAT-GARMTIGA; reverse, 5Ј-TCICCIAWRCAIHDICKYTTICC. These primers AGGGCTCGAGCGGC; Clontech) to re-amplify the 5Ј-and 3Ј-RACE products, respectively.
Step-down cycling conditions used for the RACE-PCR were expected to amplify between 321 and 336 bp. labelled with [ 32 P]dCTP and hybridized to plaque lifts (Hybond-N; Amersham) overnight in 50% formamide, 5ϫ SSC, 5ϫ Denhardts solution, 1% SDS at 42°C. Lifts were washed twice for 30 min at 68°C in each of the following solutions: 2ϫ SSC, 0.1% SDS; 0.1ϫ SSC, 0.1% SDS. The lifts were then rinsed in 2ϫ SSC and autoradiographed. Positive plaques were cored and subjected to secondary screens. The positive clones were excised using ExAssist Interference-Resistant Helper Phage with SOLR Strain (Stratagene) according to the manufacturer's instructions. The clones were grown and the plasmid DNA isolated (Maxiprep; Qiagen) and sequenced.
Results
cDNA fragments were amplified from total RNA preparations from rat oesophagus and liver by RT-PCR. In the first experiments a degenerate PCR primer pair containing inosine was used. These primers had been designed by Shen et al. (21) to amplify all P450s belonging to families 1, 2 and 3 and used by them to identify a fragment of a novel P450 from mouse embryo fibroblast cells. However, PCR with these primers did not amplify DNA from either the liver or the oesophageal cDNA. Therefore, three different sets of PCR primers were designed to amplify an equivalent 350 bp fragment of CYPs of the 2A, 2B and 2C sub-families. The positions of the primers used to detect the presence of members amplification ( Figure 2 ). The CYP2B-specific primers amplified a 350 bp cDNA fragment from both oesophageal and liver cDNA ( Figure 2 ). The band amplified in liver was more intense than that amplified from the oesophagus. Amplification with CYP2E-specific primers did not give a discernible product from oesophageal cDNA, but amplified a distinct 350 bp fragment from liver cDNA.
The CYP2B PCR product from the liver and from the oesophagus and the CYP2E PCR product from the liver were cloned into the pPCR-Script cloning vector and the cloned cDNA fragments were sequenced. Only one CYP2B clone amplified from the liver RNA was sequenced. This clone was found to have come from CYP2B2. Several different clones were sequenced from the fragment amplified from oesophageal cDNA by the CYP2B-specific primers. All of these had exactly the same sequence. The sequence had no exact matches in the multiple cloning site of pPCR-Script, but several attempts to
The 350 bp DNA fragment from oesophageal RNA obtained by RT-PCR using the CYP2B-specific primers as described above was random primer clone the 5Ј-end into the same vector were unsuccessful. Nested RACE-PCR was therefore carried out. This gave a between two and five positive clones were isolated from each of the nine clones. Plasmid DNA from these clones was more intense band from the 5Ј-end and this product could be cloned. More product was obtained from the 3Ј-end after purified. Digestion with EcoRI and XhoI of the DNA from clones 1 and 7 gave three DNA fragments, the linearized nested RACE-PCR than after the initial RACE-PCR, so this product was also cloned. Cloned plasmids containing the 3Ј-vector and the cloned cDNA which had been cut by EcoRI into two fragments of 900 and 1100 bp. The inserts in clones nested RACE-PCR product consistently contained inserts of the expected size and the inserts in four clones were sequenced 1 and 7 had identical DNA sequences. The combined length of these pieces is similar to the expected length of a CYP without difficulty. The four sequences were identical. However, plasmids containing the 5Ј-nested RACE product cDNA. Digestion of the plasmid DNA of clones 3, 6 and 9 with EcoRI and XhoI gave two fragments from the insert of contained inserts of varying sizes, ranging from 500 to 1000 bp. Sequencing of four clones containing the longest inserts lengths 1100 and 200 bp. The DNA from these clones was also sequenced. The inserted DNA in clones 3, 6 and 9 was showed that the cloned DNA fragments were overlapping parts of the same sequence, but sequencing always resulted in bad the same as that of clones 1 and 7 but shortened by 700 bp from the 5Ј-end. data towards both ends of the clones.
To overcome this problem an oesophageal cDNA library Comparison of the sequences of the cDNA library clones with those of the RACE-PCR products showed that all these was constructed as described in Materials and methods and 0.5ϫ10 6 clones were screened using as probe the 350 bp sequences were parts of a single cDNA. The sequence common to the four 5Ј-RACE products could be aligned with part of oesophageal CYP2B obtained by RT-PCR as described above. Nine positive clones were obtained. On secondary screening, the 5Ј-end of the library clones, while the 3Ј-RACE product aligned with the 3Ј-end of the library clones (Figure 1 ). The 
